Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persists

Blood

Volumn 119, Issue 15, 2012, Pages 3469-3477

  Baum, Paul D ^a   Young, Jennifer J ^a   Schmidt, Diane ^a   Zhang, Qianjun ^a   Hoh, Rebecca ^a   Busch, Michael ^b   Martin, Jeffrey ^a   Deeks, Steven ^a   McCune, Joseph M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; BLOOD ANALYSIS; CD4 LYMPHOCYTE PERCENTAGE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA HYBRIDIZATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; T LYMPHOCYTE SUBPOPULATION;

EID: 84859833150     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-11-395384     Document Type: Article

References (45)

1. Phair J, Muñoz A, Detels R, Kaslow R, Rinaldo C, Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med. 1990;322(3):161-165. (Pubitemid 20036389)
2. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126(12):946.
3. Mellors JW, Margolick JB, Phair JP, et al. Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA. 2007;297(21):2349.
4. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, Herzenberg LA. CD8 naive T-cell counts decrease progressively in HIV-infected adults. J Clin Invest. 1995;95(5):2061-2066.
5. Connors M, Kovacs JA, Krevat S, et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med. 1997;3(5):533-540. (Pubitemid 27198651)
6. Komanduri KV, Feinberg J, Hutchins RK, et al. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T-cell counts and recurrent retinitis. J Infect Dis. 2001;183(8):1285-1289. (Pubitemid 32281571)
7. Teixeira L, Valdez H, McCune JM, et al. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS. 2001;15(14):1749-1756.
8. Harris JM, Hazenberg MD, Poulin JF, et al. Multiparameter evaluation of human thymic function: interpretations and caveats. Clin Immunol. 2005;115(2):138-146. (Pubitemid 40693083)
9. McCune JM, Loftus R, Schmidt DK, et al. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest. 1998;101(11):2301-2308. (Pubitemid 28270424)
10. Napolitano LA, Lo JC, Gotway MB, et al. Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS. 2002;16(8):1103-1111. (Pubitemid 34533848)
11. Napolitano LA, Schmidt D, Gotway MB, et al. Growth hormone enhances thymic function in HIV-1-infected adults. J Clin Invest. 2008;118(3):1085-1098. (Pubitemid 351364616)
12. Levy Y, Lacabaratz C, Weiss L, et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest. 2009;119(4):997-1007.
13. Sereti I, Dunham RM, Spritzler J, et al. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood. 2009;113(25):6304- 6314.
14. Gea-Banacloche JC, Weiskopf EE, Hallahan C, et al. Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoire. J Infect Dis. 1998;177(3):579-585. (Pubitemid 28099870)
15. Gea-Banacloche JC, Martino L, Mican JM, et al. Longitudinal changes in CD4+ T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patients. AIDS Res Hum Retroviruses. 2000;16(17):1877-1886.
16. Gorochov G, Neumann AU, Kereveur A, et al. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat Med. 1998;4(2):215-221. (Pubitemid 28137377)
17. Baum PD, McCune JM. Direct measurement of T-cell receptor repertoire diversity with AmpliCot. Nat Methods. 2006;3(11):895-901. (Pubitemid 44614724)
18. Baum PD, Young JJ, Zhang Q, Kasakow Z, McCune JM. Design, construction, and validation of a modular library of sequence diversity standards for polymerase chain reaction. Anal Biochem. 2011;411(1):106-115.
19. Baum PD, Young JJ, McCune JM. Measurement of absolute T cell receptor rearrangement diversity. J Immunol Methods. 2011;368(1):45-53.
20. Westermann J, Pabst R. Distribution of lymphocyte subsets and natural killer cells in the human body. J Clin Invest. 1992;70(7):539-544.
21. Rowen L, Koop BF, Hood L. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. Science. 1996;272(5269):1755-1762. (Pubitemid 26256389)
22. Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002;169(4):1984-1992. (Pubitemid 34857662)
23. Pourgheysari B, Khan N, Best D, Bruton R, Nayak L, Moss PA. The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol. 2007;81(14):7759-7765. (Pubitemid 47047862)
24. + T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J Immunol. 1995;155(10):5046-5056.
25. Hadrup SR, Strindhall J, Køllgaard T, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus- specific T cells in the very elderly. J Immunol. 2006;176(4):2645-2653. (Pubitemid 43201717)
26. Naylor K, Li G, Vallejo AN, et al. The influence of age on T cell generation and TCR diversity. J Immunol. 2005;174(11):7446.
27. Khalifa MM, Sharaf RR, Aziz RK. Helicobacter pylori: a poor man's gut pathogen? Gut Pathog. 2010;2(1):2.
28. Robins HS, Campregher PV, Srivastava SK, et al. Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells. Blood. 2009;114(19):4099-4107.
29. Klarenbeek PL, Tak PP, van Schaik BD, et al. Human T-cell memory consists mainly of unexpanded clones. Immunol Lett. 2010;133(1):42-48.
30. Sieg SF, Bazdar DA, Lederman MM. S-phase entry leads to cell death in circulating T cells from HIV-infected persons. J Leukoc Biol. 2008;83(6):1382-1387. (Pubitemid 351960318)
31. + effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med. 2007;204(9):2171-2185.
32. Warren RL, Freeman JD, Zeng T, et al. Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome Res. 2011;21(5):790-797.
33. Venturi V, Quigley MF, Greenaway HY, et al. A mechanism for TCR sharing between T-cell subsets and individuals revealed by pyrosequencing. J Immunol. 2011;186(7):4285-4294.
34. +) central and effector memory T-cell subsets are largely distinct. Immunity. 2003;18(2):193-204.
35. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature. 2004;432(7018):769-775.
36. Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med. 2008;205(3):711.
37. Cicin-Sain L, Smyk-Pearson S, Smyk-Paerson S, et al. Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primates. J Immunol. 2010;184(12):6739-6745.
38. D'Egidio GE, Kravcik S, Cooper CL, Cameron DW, Fergusson DA, Angel JB. Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count< 200 cells/μL when viral replication is suppressed. AIDS. 2007;21(13):1711-1715. (Pubitemid 47237557)
39. Mocroft A, Reiss P, Kirk O, et al. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/μL? Clin Infect Dis. 2010;51(5):611-619.
40. Sellier P, Lafuente-Lafuente C, Bergmann JF, Neaton JD, Lévy Y, Lane HC. Interleukin-2 therapy in patients with HIV infection. N Engl J Med. 2010;362(3):270-271.
41. Betts MR, Ambrozak DR, Douek DC, et al. Analysis of total human immunodeficiency virus (HIV)- specific CD4(+) and CD8() T-cell responses: relationship to viral load in untreated HIV infection. J Virol. 2001;75(24):11983-11991. (Pubitemid 33115870)
42. Lyles RH, Chu C, Mellors JW, et al. Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex: Multicenter AIDS Cohort Study. AIDS. 1999;13(3):341-349. (Pubitemid 29095096)
43. Sportès C, Hakim FT, Memon SA, et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T-cell subsets. J Exp Med. 2008;205(7):1701-1714. (Pubitemid 351962032)
44. + T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers. J Virol. 2010;84(19):10354-10365.
45. Douek DC, Brenchley JM, Betts MR, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature. 2002;417(6884):95-98. (Pubitemid 34498823)